Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Kyphoplasty Market, by Product Type
1.4.2 North America Kyphoplasty Market, by Indication
1.4.3 North America Kyphoplasty Market, by End User
1.4.4 North America Kyphoplasty Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Kyphoplasty Market by Product Type
4.1 North America Accessories Market by Country
4.2 North America Kyphoplasty Systems Market by Country
Chapter 5. North America Kyphoplasty Market by Indication
5.1 North America Osteoporosis Market by Country
5.2 North America Others Market by Country
Chapter 6. North America Kyphoplasty Market by End User
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Ambulatory Surgical Centers Market by Country
Chapter 7. North America Kyphoplasty Market by Country
7.1 US Kyphoplasty Market
7.1.1 US Kyphoplasty Market by Product Type
7.1.2 US Kyphoplasty Market by Indication
7.1.3 US Kyphoplasty Market by End User
7.2 Canada Kyphoplasty Market
7.2.1 Canada Kyphoplasty Market by Product Type
7.2.2 Canada Kyphoplasty Market by Indication
7.2.3 Canada Kyphoplasty Market by End User
7.3 Mexico Kyphoplasty Market
7.3.1 Mexico Kyphoplasty Market by Product Type
7.3.2 Mexico Kyphoplasty Market by Indication
7.3.3 Mexico Kyphoplasty Market by End User
7.4 Rest of North America Kyphoplasty Market
7.4.1 Rest of North America Kyphoplasty Market by Product Type
7.4.2 Rest of North America Kyphoplasty Market by Indication
7.4.3 Rest of North America Kyphoplasty Market by End User
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Partnerships, Collaborations and Agreements:
8.1.5.3 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Stryker Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Geographical Expansions:
8.2.5.2 Approvals and Trials:
8.3 MicroPort Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 IZI Medical Products, LLC (Landauer, Inc.)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Product Launches and Product Expansions:
8.4.2.2 Acquisition and Mergers:
8.5 Merit Medical Systems, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Jiangsu Changmei Medtech Co., Ltd.
8.6.1 Company Overview
8.7 G21 S.r.l.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Approvals and Trials:
8.8 Seawon Meditech Co., Ltd.
8.8.1 Company Overview
8.9 joimax® GmbH
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. Taeyeon Medical Co., Ltd.
8.10.1 Company Overview
Unique Offerings 